Lidak Pharm. [LDAKA] | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Lidak Pharm. [LDAKA]

An SI Board Since November 1996

Posts	SubjectMarks	Bans	Symbol
1115	2	0	LDAKA

Emcee: Barry Rost	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
465	OTC makes a lot of sense for topical anti-viral--would pressure zovirax. if the	chirodoc	-	8/20/1997
464	To All: I'm wondering if the Valtrex hype is confusing the market and steal	Dan Shubin	-	8/20/1997
463	Henry, Check out IMUL. If your patient and are in it for the long haul,	HERB MILLER	-	8/20/1997
462	Don't forget IGEN International. Also way underrated and underpriced. Sub	John Zwiener	-	8/19/1997
461	Michael took a peek at your personal profile and you seem to be just the perso	henry jakala	-	8/19/1997
460	i'm having a problem understanding why Lidakol will have to be a prescripti	henry jakala	-	8/19/1997
459	Another potential advantage of Lidakol (N-docosanol) vs. Zovirax (acyclovir):	MCorbley	-	8/19/1997
458	lidak looks promising--also look at genzymes, amgen, biogen, ligand, incyte for	chirodoc	-	8/19/1997
457	lower toxicity is obviously a plus. patients will eventually choose the less to	chirodoc	-	8/19/1997
456	Chirodoc This is my understanding of Lidakol vs. Zovirax: Lidakol was as effe	MCorbley	-	8/19/1997
455	Lidak has never really followed the markets rhythym that closely before but may	Henry Volquardsen	-	8/19/1997
454	we've given back friday's gains in almost everything--this was a BROAD	chirodoc	-	8/19/1997
453	thanks for the post regarding lidak and trials vs. zovirax. it does sound effec	chirodoc	-	8/19/1997
452	LUUUUIIIISSSS. It's the NDA to get approval. They say they will file by t	John Zwiener	-	8/19/1997
451	One other theory on price drop. BI Research recommended sell it if the price d	ML Harper	-	8/19/1997
450	The R&D expenses were $4.6 M, 7.7 M, and 3.1 M, respectively, for fiscal 19	MCorbley	-	8/19/1997
449	John what approval are you referring to? the pma/nda whatever application for d	luis a. garcia	-	8/18/1997
448	Henry I agree with your market makers comments... they are nothing if not corru	luis a. garcia	-	8/18/1997
447	Analog, I think somewhere in the vicinity of 5 mill. However is less than that	luis a. garcia	-	8/18/1997
446	Michael you are correct, Its what affords us the opportunities.. in the first	luis a. garcia	-	8/18/1997
445	Almost all biotechs (except giron) seem to drop on news, even good. Lidak follo	John Zwiener	-	8/18/1997
444	Luis, I am in today at $3.00. I paid extra thousand buck for limit order. No t	Roland Chen	-	8/18/1997
443	why did Lidak's stock price fall today you ask ??? well.... maybe becaus	henry jakala	-	8/18/1997
442	Henry, Very funny note. I bought more today, too. For me, it was to average	Linda Kaplan	-	8/18/1997
441	Anybody have the figures for what Lidak spent on R&D the last 5 years? I r	Analog Kid	-	8/18/1997

Go to reply# or date (mm/dd/yy):